Nature

订阅

MedSci主页 / 所有栏目 / Nature

Springer Nature医学与健康科学开放获取期刊 ： 2019期刊指标

2019-07-18 BMC 中国 BMC 期刊

SpringerNature医学健康
关注

备受瞩目的2019年度《期刊引证报告》在2019年6月20日正式发布。在此，整理出施普林格•自然旗下医学与健康科学开放获取期刊的最新期刊指标，供大家先睹为快。

备受瞩目的2019年度《期刊引证报告》在2019年6月20日正式发布。在此，整理出施普林格•自然旗下医学与健康科学开放获取期刊的最新期刊指标，供大家先睹为快。


















Nature Research、BMC以及SpringerOpen 已签署了《旧金山科研评估宣言》（DORA），并将一如既往地主张以一系列不同的指标来评估期刊。

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2027871, encodeId=6aff202e87177, content=<a href='/topic/show?id=4ac41664521' target=_blank style='color:#2F92EE;'>#Springer#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16645, encryptionId=4ac41664521, topicName=Springer)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a8d381, createdName=mnda, createdTime=Mon Jul 22 23:39:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1883767, encodeId=716a1883e67e9, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jun 17 11:39:00 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665755, encodeId=497c1665e55e6, content=<a href='/topic/show?id=aa8e49656e2' target=_blank style='color:#2F92EE;'>#开放获取#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49656, encryptionId=aa8e49656e2, topicName=开放获取)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a25999447, createdName=ms4657536712156177, createdTime=Wed Sep 11 19:39:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021665, encodeId=c7e1202166582, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Dec 13 12:39:00 CST 2019, time=2019-12-13, status=1, ipAttribution=)]
    2019-07-22 mnda

    #Springer#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2027871, encodeId=6aff202e87177, content=<a href='/topic/show?id=4ac41664521' target=_blank style='color:#2F92EE;'>#Springer#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16645, encryptionId=4ac41664521, topicName=Springer)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a8d381, createdName=mnda, createdTime=Mon Jul 22 23:39:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1883767, encodeId=716a1883e67e9, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jun 17 11:39:00 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665755, encodeId=497c1665e55e6, content=<a href='/topic/show?id=aa8e49656e2' target=_blank style='color:#2F92EE;'>#开放获取#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49656, encryptionId=aa8e49656e2, topicName=开放获取)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a25999447, createdName=ms4657536712156177, createdTime=Wed Sep 11 19:39:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021665, encodeId=c7e1202166582, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Dec 13 12:39:00 CST 2019, time=2019-12-13, status=1, ipAttribution=)]
    2020-06-17 liye789132251

    #Nat#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2027871, encodeId=6aff202e87177, content=<a href='/topic/show?id=4ac41664521' target=_blank style='color:#2F92EE;'>#Springer#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16645, encryptionId=4ac41664521, topicName=Springer)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a8d381, createdName=mnda, createdTime=Mon Jul 22 23:39:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1883767, encodeId=716a1883e67e9, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jun 17 11:39:00 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665755, encodeId=497c1665e55e6, content=<a href='/topic/show?id=aa8e49656e2' target=_blank style='color:#2F92EE;'>#开放获取#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49656, encryptionId=aa8e49656e2, topicName=开放获取)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a25999447, createdName=ms4657536712156177, createdTime=Wed Sep 11 19:39:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021665, encodeId=c7e1202166582, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Dec 13 12:39:00 CST 2019, time=2019-12-13, status=1, ipAttribution=)]
    2019-09-11 ms4657536712156177

    #开放获取#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2027871, encodeId=6aff202e87177, content=<a href='/topic/show?id=4ac41664521' target=_blank style='color:#2F92EE;'>#Springer#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16645, encryptionId=4ac41664521, topicName=Springer)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a8d381, createdName=mnda, createdTime=Mon Jul 22 23:39:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1883767, encodeId=716a1883e67e9, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jun 17 11:39:00 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665755, encodeId=497c1665e55e6, content=<a href='/topic/show?id=aa8e49656e2' target=_blank style='color:#2F92EE;'>#开放获取#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49656, encryptionId=aa8e49656e2, topicName=开放获取)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a25999447, createdName=ms4657536712156177, createdTime=Wed Sep 11 19:39:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021665, encodeId=c7e1202166582, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Dec 13 12:39:00 CST 2019, time=2019-12-13, status=1, ipAttribution=)]
    2019-12-13 12498c32m68暂无昵称

    #GER#

    0

相关资讯

《自然》出版集团和德国Springer合并 成为全球领先

根据来自《自然》网站的报道，自然出版集团和德国Springer合并，这次合并使该公司的杂志数量超过将产生世界拥有杂志最多的出版公司Elsevier (3,057)，成为拥有学术杂志最多的出版集团。 自然集团是伦敦的麦克米伦科学和教育公司，虽然这个公司的规模比较小，但该公司旗下拥有《自然》、自然子刊和《科学美国人》等众多高水平期刊，在国际学术出版行业有非常重要的地位。Springer是德国柏林的科

Springer Nature医学与健康科学开放获取期刊：2019期刊指标

备受瞩目的2019年度《期刊引证报告》在2019年6月20日正式发布。在此，整理出施普林格•自然旗下医学与健康科学开放获取期刊的最新期刊指标，供大家先睹为快。

Springer Nature医学与健康科学开放获取期刊 ： 2019期刊指标

备受瞩目的2019年度《期刊引证报告》在2019年6月20日正式发布。在此，整理出施普林格•自然旗下医学与健康科学开放获取期刊的最新期刊指标，供大家先睹为快。